Health Condition 1: F315- Bipolar disorder, current episodedepressed, severe, with psychotic features Health Condition 2: F314- Bipolar disorder, current episodedepressed, severe, without psychotic features Health Condition 3: F312- Bipolar disorder, current episodemanic severe with psychotic features Health Condition 4: F316- Bipolar disorder, current episodemixed Health Condition 5: F319- Bipolar disorder, unspecified Health Condition 6: F202- Catatonic schizophrenia Health Condition 7: F22- D
Conditions
Interventions
Intervention1: Ketodex: Injection. Dexmedetomidine 0.5 μg/kg (diluted to 10 ml with 0.9% saline) will be infused over 10 min followed by induction with Ketamine 1 mg/kg. Additional ketamine will be g
Sponsors
Mahatma Gandhi Medical College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: Undergoing ECT for any indication Giving consent
Exclusion criteria
Exclusion criteria: Serious physical disease, such as cardiovascular disease, cerebrovascular disorder, intracranial hypertension, respiratory tract disease, History of previous fracture. History of Glaucoma, Presence of a pacemaker, History of seizures, ASA III â??V physical status, History of allergy to the study drugs, and Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart Rate, Systolic and Diastolic Blood PressureTimepoint: baseline, 5, 10, 20, 30, 40, 50 and 60 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Motor SeizureTimepoint: Once at the end of Seizure;Incidence of Adverse EventsTimepoint: At the end of the Procedure;SpO2Timepoint: baseline, 5, 10, 20, 30, 40, 50 and 60 minutes | — |
Countries
India
Contacts
Public ContactAvudaiappan Sankaran
Mahatma Gandhi Medical College and Research Institute
Outcome results
None listed